Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals

• Main Authors: Emersom C. Mesquita, Eugenio D. Hottz, Rodrigo T. Amancio, Alan B. Carneiro, Lohanna Palhinha, Lara E. Coelho, Beatriz Grinsztejn, Guy A. Zimmerman, Matthew T. Rondina, Andrew S. Weyrich, Patrícia T. Bozza, Fernando A. Bozza
• Format: Article
• Language: English
• Published: Nature Publishing Group 2018-10-01
• Series: Scientific Reports
• Subjects: Increased Platelet Activation; Virologic Suppression; RANTES Secretion; Stable cART; Platelet Spreading
• Online Access: https://doi.org/10.1038/s41598-018-33403-0

Abstract Cardiovascular diseases and thrombotic events became major clinical problems in the combined antiretroviral therapy (cART) era. Although the precise mechanisms behind these clinical problems have not been fully elucidated, a persistent pro-inflammatory state plays a central role. As platelets play important roles on both, thrombus formation and inflammatory/immune response, we aimed at investigating platelet function in HIV-infected subjects virologically controlled through cART. We evaluate parameters of activation, mitochondrial function and activation of apoptosis pathways in platelets from 30 HIV-infected individuals under stable cART and 36 healthy volunteers. Despite viral control achieved through cART, HIV-infected individuals exhibited increased platelet activation as indicated by P-selectin expression and platelet spreading when adhered on fibrinogen-coated surfaces. Platelets from HIV-infected subjects also exhibited mitochondrial dysfunction and activation of apoptosis pathways. Finally, thrombin stimuli induced lower levels of P-selectin translocation and RANTES secretion, but not TXA2 synthesis, in platelets from HIV-infected individuals compared to control; and labeling of platelet alpha granules showed reduced granule content in platelets from HIV-infected individuals when compared to healthy subjects. In summary, platelets derived from HIV-infected individuals under stable cART exhibit a phenotype of increased activation, activation of the intrinsic pathway of apoptosis and undermined granule secretion in response to thrombin.